OTC:RVPH | Profit Breakdown | REVIVA PHARMACEUTICALS HOLDINGS, INC.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2018-05-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$2.62M-$2.45M-$2.45M
2026-03-31-$3.27M-$3.19M-$3.2M
2025-12-31-$3.56M-$3.36M-$3.37M
2025-09-30-$4.03M-$4.01M-$4.01M
2025-06-30-$6.07M-$6.05M-$6.05M
2025-03-31-$6.54M-$6.43M-$6.43M
2024-12-31-$6.28M-$6.25M-$6.26M
2024-09-30-$8.46M-$8.37M-$8.37M
2024-06-30-$8.13M-$7.85M-$7.86M
2024-03-31-$7.92M-$7.43M-$7.43M
2023-12-31-$9.62M-$9.36M-$9.36M
2023-09-30-$11.56M-$11.33M-$11.35M
2023-06-30-$11.34M-$11.7M-$11.71M
2023-03-31-$6.98M-$6.85M-$6.85M
2022-12-31-$8.89M-$12.03M-$9.24M
2022-09-30-$3.56M-$3.51M-$3.52M
2022-06-30-$5.52M-$5.33M-$5.34M
2022-03-31-$7.45M-$7.36M-$7.37M
2021-12-31-$3.96M-$3.68M-$3.68M
2021-09-30-$2.48M-$2.28M-$2.28M
2021-06-30-$1.79M-$1.6M-$1.61M
2021-03-31-$1.87M-$948,500.00-$949,300.00
2020-12-31-$526,698.00-$1.52M-$1.52M
2020-11-30-$352,007.00-$348,207.00
2020-09-30-$512,291.00-$658,541.00-$659,088.00
2020-08-31-$525,924.00-$516,032.00
2020-06-30-$777,384.00-$851,433.00-$851,433.00
2020-05-31-$264,941.00-$155,766.00
2020-03-31-$618,277.00-$748,162.00-$748,962.00
2020-02-29-$393,473.00-$131,651.00
2019-11-30-$166,022.00$136,808.00
2019-08-31-$94,110.00$274,320.00
2019-05-31-$71,135.00$338,426.00
2019-02-28-$57,974.00$306,562.00
2018-11-30-$79,146.00$263,223.00
2018-08-31-$2,328.00$17,687.00
2018-05-31-$13,341.00-$13,341.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$20.2M-$19.85M-$19.86M
2024-12-31-$30.8M-$29.9M-$29.92M
2023-12-31-$39.5M-$39.24M-$39.26M
2022-12-31-$28.23M-$28.24M-$28.26M
2021-12-31-$10.1M-$8.52M-$8.52M
2021-12-13-$10.1M-$8.52M-$8.52M
2020-12-31-$2.43M-$3.78M-$3.78M
2020-02-29-$724,740.00$617,903.00
2019-12-31-$376,860.00-$846,032.00-$846,832.00
2019-02-28-$152,789.00$574,131.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.